Mutagenicity at the Hprt locus in T cells of female mice following inhalation exposures to low levels of 1,3-butadiene

Huff, 1985, Multiple organ carcinogenicity of 1,3-butadiene in B6C3F1 mice after 60 weeks of inhalation exposure, Science, 227, 548, 10.1126/science.3966163 Owen, 1987, Inhalation toxicity studies with 1,3-butadiene. 3. Two-year toxicity/carcinogenicity studies in rats, Am. Ind. Hyg. Assoc. J., 48, 407, 10.1080/15298668791384959 Melnick, 1990, Carcinogenicity of 1,3-butadiene in C57BL/6×C3H F1 mice at low exposure concentrations, Cancer Res., 50, 6592 Melnick, 1992, 1,3-Butadiene: Toxicity and carcinogenicity in laboratory animals and in humans, Rev. Environ. Contam. Toxicol., 124, 111 Landrigan, 1993, Critical assessment of epidemiological studies on the carcinogenicity of 1,3-butadiene and styrene, 127, 375 Divine, 1996, Mortality update of butadiene production workers, Toxicology, 113, 169, 10.1016/0300-483X(96)03442-7 Delzell, 1996, A follow-up study of synthetic rubber workers, Toxicology, 113, 182, 10.1016/0300-483X(96)03443-9 Himmelstein, 1997, Toxicology and epidemiology of 1,3-butadiene, CRC Rev. Toxicol., 27, 1, 10.3109/10408449709037482 Melnick, 1995, Mechanistic data indicate that 1,3-butadiene is a human carcinogen, Carcinogenesis, 16, 157, 10.1093/carcin/16.2.157 Bond, 1995, Epidemiological and mechanistic data suggest that 1,3-butadiene will not be carcinogenic to humans at exposures likely to be encountered in the environment or workplace, Carcinogenesis, 16, 165, 10.1093/carcin/16.2.165 Cunningham, 1986, In vivo sister chromatid exchange and micronucleus induction studies with 1,3-butadiene in B6C3F1 mice and Sprague–Dawley rats, Mutagenesis, 1, 449 Autio, 1994, Induction of micronuclei in peripheral blood and bone marrow erythrocytes of rats and mice exposed to 1,3-butadiene by inhalation, Mutat. Res., 309, 315, 10.1016/0027-5107(94)90108-2 Anderson, 1997, Somatic and germ cell effects in rats and mice after treatment with 1,3-butadiene and its metabolites, 1,2-epoxybutene and 1,2,3,4-diepoxybutane, Mutat. Res., 391, 233, 10.1016/S1383-5718(97)00069-7 Cochrane, 1994, Mutagenicity of butadiene and its epoxide metabolites. II: Mutational spectrum of butadiene, 1,2-epoxybutene and diepoxybutane at the hprt locus in splenic T cells from exposed B6C3F1 mice, Carcinogenesis, 15, 719, 10.1093/carcin/15.4.719 Tates, 1994, Development of a cloning assay with high cloning efficiency to detect induction of 6-thioguanine-resistant lymphocytes in spleen of adult mice following in vivo inhalation exposure to 1,3-butadiene, Mutat. Res., 309, 299, 10.1016/0027-5107(94)90106-6 Meng, 1998, Comparison of the mutagenic potency of 1,3-butadiene at the hprt locus of lymphocytes following inhalation exposure of female B6C3F1 mice and F344 rats, Carcinogenesis, 19, 1019, 10.1093/carcin/19.6.1019 Meng, 1999, Mutagenicity of 1,3-butadiene at the hprt locus of T-cells following inhalation exposures of female mice and rats, Mutat. Res., 429, 107, 10.1016/S0027-5107(99)00104-9 Walker, 2000, In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites, 89 Ward, 1996, Assessment of butadiene exposure in a rubber plant using a urine metabolite and HPRT mutant frequency as biological markers of exposure and effect, Environ. Mol. Mutagen., 27, 73 Ward, 1996, Biological monitoring for mutagenic effects of occupational exposures to butadiene, Toxicology, 113, 84, 10.1016/0300-483X(96)03431-2 Tates, 1996, Biological effect monitoring in the industrial workers from the Czech Republic exposed to low levels of butadiene, Toxicology, 113, 91, 10.1016/0300-483X(96)03432-4 Hayes, 1996, Hprt mutation frequency among workers exposed to 1,3-butadiene in China, Toxicology, 113, 100, 10.1016/0300-483X(96)03433-6 J.A. Swenburg, N.I. Christova-Gueorguieva, N. Scheller, A. Ranasinghe, Quantitation of epoxybutene and trihydroxybutane hemoglobin adducts within exposed and control mice, rats and humans, in: Proceedings of the Fourteen Health Effects Institute Annual Conference, 1998, p. 54. R.J. Albertini, R.J. Šrám, Biomarker response in butadiene-exposed Czech workers: a transitional epidemiological study, in: Proceedings of the Fourteen Health Effects Institute Annual Conference, 1998, p. 49. Recio, 2000, Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity, 49 Meng, 1998, Culture and propagation of Hprt mutant T-lymphocytes isolated from mouse spleen, Environ. Mol. Mutagen., 32, 236, 10.1002/(SICI)1098-2280(1998)32:3<236::AID-EM6>3.0.CO;2-Y Meng, 1999, Mutagenicity of epoxybutene and diepoxybutane at the Hprt locus of T-cells following inhalation exposures of mice and rats, Mutat. Res., 429, 127, 10.1016/S0027-5107(99)00105-0 Albertini, 1985, Somatic gene mutations in vivo as indicated by the 6-thioguanine-resistant T-lymphocytes in human blood, Mutat. Res., 150, 411, 10.1016/0027-5107(85)90138-1 Cole, 1988, Human population monitoring: a further assessment of factors influencing measurements of thioguanine-resistant mutant frequency in circulating T-lymphocytes, Mutat. Res., 204, 493, 10.1016/0165-1218(88)90044-4 Tates, 1991, Use of the clonal assay for the measurement of frequencies of HPRT mutants in T-lymphocytes from five control populations, Mutat. Res., 253, 199, 10.1016/0165-1161(91)90133-S Finette, 1994, Determination of hprt mutant frequencies in T-lymphocytes from a healthy pediatric population: statistical comparison between newborn, children and adult mutant frequencies, cloning efficiency and age, Mutat. Res., 308, 223, 10.1016/0027-5107(94)90157-0 H.E. Sussman, M.J. Bauer, X. Shi, S.A. Judice, R.J. Albertini, V.E. Walker, Transplacental mutagenicity of N-ethyl-N-nitrosourea at the Hprt locus in T-lymphocytes of exposed B6C3F1 mice, Environ. Mol. Mutagen. (2001) in press. Finette, 1998, Gene mutations with characteristic deletions in cord blood T lymphocytes with passive maternal exposure to tobacco smoke, Nat. Med., 4, 1144, 10.1038/2640 J.P. O'Neill, HPRT mutant frequency and mutation spectrum in newborns with perinatal exposure to antiretroviral drugs, Environ. Mol. Mutagen. 37, Suppl. 32 (2001) 58. O'Neill, 1994, The effect of T-lymphocyte ‘clonality’ on the calculated hprt mutation frequency occurring in vivo in humans, Mutat. Res., 313, 215, 10.1016/0165-1161(94)90052-3 Crippen, 1989, Cell proliferation in the bone marrow, thymus and spleen of mice studied by continuous, in vivo bromodeoxycytidine labeling and flow cytometric analysis, Cell Tissue Kinet., 22, 203 Walker, 1999, Relationships between exposure, cell loss and proliferation, and manifestation of Hprt mutant T cells following treatment of preweanling, weanling, and adult male mice with N-ethyl-N-nitrosourea, Mutat. Res., 431, 371, 10.1016/S0027-5107(99)00180-3 Finette, 1996, V(D)J recombinase-mediated HPRT mutations in peripheral blood lymphocytes of normal children, Cancer Res., 56, 1405 Koc, 1999, Molecular dosimetry of N-7-guanine adduct formation in mice and rats exposed to 1,3-butadiene, Chem. Res. Toxicol., 12, 566, 10.1021/tx980265f Ma, 2000, Molecular analysis of hprt mutant lymphocytes from 1,3-butadiene-exposed workers, Environ. Mol. Mutagen., 36, 59, 10.1002/1098-2280(2000)36:1<59::AID-EM9>3.0.CO;2-#